Results 101 to 110 of about 49,840 (263)
Use of Succinylcholine in the Presence of Atypical Cholinesterase [PDF]
Stanley Leeson +3 more
openalex +1 more source
Abstract Background Mild behavioral impairment (MBI) is a syndrome characterized by the later‐life onset of neuropsychiatric symptoms (NPS) and serves as a potential marker for dementia. In Parkinson's disease (PD), MBI has been associated with worse cognition, cortical atrophy, and altered connectivity.
Gabriel D. Pinilla‐Monsalve +4 more
wiley +1 more source
Cholinesterase Activity in Quails of Neuropathy Caused by Organophosphates.
Hideo Kinebuchi +3 more
openalex +2 more sources
Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease
Abstract Background As Parkinson's disease (PD) progresses, managing symptoms becomes increasingly difficult. Foslevodopa/foscarbidopa (LDp/CDp), a 24‐hour/day continuous subcutaneous infusion of levodopa/carbidopa (LD/CD) prodrugs, improves motor complications.
Jason Aldred +11 more
wiley +1 more source
Video Urodynamic Study in Patients with Parkinson's Disease and Multiple System Atrophy
Abstract Background Most studies have analyzed the urodynamic characteristics of patients with Parkinson's disease (PD) and multiple system atrophy (MSA) using conventional urodynamic studies. Objectives This study investigated the urodynamic characteristics of both diseases using video urodynamic study (VUDS).
Hyun Sik Yoon +3 more
wiley +1 more source
A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier +12 more
wiley +1 more source

